Keel Point, LLC Eli Lilly & CO Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Keel Point, LLC holds 2,897 shares of LLY stock, worth $2.22 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,897

Previous 3,019 4.04%

Holding current value

$2.22 Million

Previous $2.73 Million 6.11%

% of portfolio

0.22%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $94,201 - $117,122	-122 Reduced 4.04%	2,897 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $574,821 - $720,868	793 Added 35.62%	3,019 $2.73 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $98,305 - $131,518	166 Added 8.06%	2,226 $1.73 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $25,734 - $30,337	49 Added 2.44%	2,060 $1.2 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 1.51%	2,011 $1.08 Million
Q2 2023 Jul 12, 2023	BUY	$350.74 - $468.98 $47,700 - $63,781	136 Added 7.37%	1,981 $929,000
Q1 2023 Apr 03, 2023	SELL	$310.63 - $364.82 $8,076 - $9,485	-26 Reduced 1.39%	1,845 $633,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $55,306 - $64,443	172 Added 10.12%	1,871 $0
Q3 2022 Oct 05, 2022	BUY	$296.48 - $337.87 $3,557 - $4,054	12 Added 0.71%	1,699 $549,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $39,579 - $46,472	-142 Reduced 7.76%	1,687 $514,000
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $1,173 - $1,458	-5 Reduced 0.27%	1,829 $524,000
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $24,058 - $29,857	-107 Reduced 5.51%	1,834 $506,000
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $430,125 - $529,330	1,941 New	1,941 $448,000
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $271,186 - $350,777	-1,502 Closed	0 $203,000
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $722 - $934	4 Added 0.27%	1,502 $345,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $38,286 - $49,563	233 Added 18.42%	1,498 $280,000
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $17,481 - $23,132	-134 Reduced 9.58%	1,265 $214,000
Q3 2020 Nov 18, 2020	BUY	$146.22 - $169.13 $204,561 - $236,612	1,399 New	1,399 $207,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $577,698 - $679,993	-5,190 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $44,132 - $55,157	514 Added 10.99%	5,190 $557,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $158,970 - $182,448	-2,100 Reduced 30.99%	4,676 $399,000
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $58,551 - $69,116	-789 Reduced 10.43%	6,776 $524,000
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $16,388 - $17,578	-200 Reduced 2.58%	7,565 $639,000
Q2 2017 Aug 15, 2017	BUY	N/A	7,765	7,765 $639,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account